GlobeNewswire by notified

J.M. Huber Corporation Signs Agreement to Acquire the Biolchim Group From NB Renaissance, Chequers Capital and Management Team

Share

ATLANTA, Aug. 08, 2022 (GLOBE NEWSWIRE) -- J.M. Huber Corporation (Huber)—a global, family-owned specialty engineered materials manufacturing company—announced today that it has signed a binding agreement to acquire full control of the Biolchim Group from NB Renaissance, Chequers Capital and the Biolchim Group management team. The Biolchim Group, managed and headed by Galileo Quattro SARL, has its main operating base in Italy and is a leading producer and distributor of a full range of specialty plant nutrition and biostimulants. Closing of the sale, anticipated to occur by the end of 2022, is subject to customary closing conditions including the foreign direct investment approval in Italy.

All the companies in the Biolchim Group—including Biolchim S.p.A, Cifo, Ilsa S.p.A, Matécsa Kft, and West Coast Marine-Bio Processing Corp.—are within the scope of the purchase. The Biolchim Group operates eight production plants globally and its products—biostimulants, trace elements, and water soluble, liquid and foliar fertilizers—are present in over 70 countries worldwide. The Biolchim Group has a rich 50-year history of serving the agricultural industry.

Upon close of the sale, the Biolchim Group will become part of Huber Engineered Materials (HEM), a company within the Huber portfolio of businesses. The Biolchim Group will be a key part of the strategic foundation of the Huber AgroSolutions (HAS) business unit of HEM that currently includes Miller Chemical & Fertilizer (Miller).

Leonardo Valenti, CEO of the Biolchim Group since 2008 and a pioneer in the plant nutrition industry, will remain committed to lead the Biolchim Group through the next phase of growth and the integration, leveraging the synergy potential of the strategic combination of both entities.

Huber AgroSolutions’ vision is to become a leading formulator of sustainable, high-performing agricultural products globally. The acquisition of the Biolchim Group, which has achieved impressive growth due to its broad offering of biostimulant and specialty nutritional products, significantly advances this vision by bringing an innovative and entrepreneurial workforce and culture to HAS. Together the companies share a culture that is deeply committed to plant nutrition and the success of its many customers around the globe.

The complementary sales footprint of both companies will enable expanded customer and product access into key agricultural regions globally. In addition to remaining committed to serve the Biolchim Group’s existing customer base, this also ideally positions HAS to advance the sales of the Biolchim Group’s products through its strong relationships with US-based growers and its complementary distribution network in Latin America and select countries in Europe, the Middle East and Africa. The Biolchim Group’s sales channels are ideally suited to advance the sales of various Miller products via its strength in Europe and its global subsidiary network.

“I am excited and energized about this opportunity to combine two successful businesses, Miller and the Biolchim Group,” says David Riley, Senior Vice President and General Manager of Huber AgroSolutions. “I am also thankful to Mr. Valenti for his leadership and support as we transition the Biolchim Group and Miller to the next phase of growth.”

Leonardo Valenti, CEO of the Biolchim Group, says, “The strategic combination of the Biolchim Group and Huber AgroSolutions will be transformative since the companies have complementary commercial and product offerings, as well as industry-leading technologies and research capacities. We are both eager to collaborate, share knowledge and build on each other’s capabilities. The agreement will open up new growth ambitions and will position us as a leading player in specialty nutrition globally. I am excited about the promising future for the company, and I am grateful to NB Renaissance and Chequers Capital for the continuous support received over the past several years through the implementation of the Biolchim Group’s value creation plan and the key strategic decisions.”

“Miller and the Biolchim Group create a powerful combination of brands, people and specialty products that will bring tremendous value to our respective customers globally,” says Dan Krawczyk, President of HEM. “We’re extremely excited to welcome the Biolchim Group’s employees to Huber given the similarities in our cultures, values and goals. Together we will work to shape the future of the organization and build a leading global business in the agriculture industry.”

Gretchen McClain, President and CEO of J.M. Huber Corporation, adds, “This combination furthers our commitment to provide innovative products and solutions to the global agriculture industry. Enabling food security for people around the world supports Huber’s overall sustainability commitment and strategy.”

Huber is being advised on the purchase by Rabobank and Jefferies, and Jones Day is acting as legal counsel to Huber on the transaction.

About J.M. Huber Corporation
J.M. Huber Corporation, headquartered in Atlanta, Georgia (US), operates a diverse portfolio of companies: CP Kelco, Huber Engineered Materials, Huber Engineered Woods and Huber Resources Corp. With locations around the world, our businesses create products used in a broad range of applications including personal care, food and beverage, agricultural nutrients and adjuvants, building materials, flame retardants and smoke suppressants, as well as sustainable forestry services. Founded in 1883, Huber is one of the largest family-owned companies based in the US. For more information, visit www.huber.com.

About Huber Engineered Materials
Huber Engineered Materials (HEM), headquartered in Atlanta, Georgia (US) is focused on engineered specialty chemical and minerals that enhance the performance, appeal and processing of a broad range of products used in industrial, agricultural and consumer applications. HEM’s AgroSolutions strategic business unit also has a portfolio of high value agricultural nutrients and adjuvants that it delivers to customers in the agriculture industry through a global network of distributors. For more information, visit www.hubermaterials.com.

MEDIA CONTACT:
Lea Volpe
Director, Corporate Communications
J.M. Huber Corporation
678.247.7128 phone
lea.volpe@huber.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Correction to Company announcement – No. 23 / 202419.4.2024 22:20:51 CEST | Press release

Correction to Company announcement – No. 23 / 2024 Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has a correction to company announcement No. 23 /2024, April 19, 2024 - regarding transactions in Zealand’s shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons it was reported that member of the management, Henriette Wennicke, was allocated a total of 8,008 restricted stock units with a total value of DKK 9,577,568.00. The correct number was a total of 8,008 restricted stock units with a total value of DKK 4,788,784.00. Please see the attached file(s). # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10

Nokia Corporation: Repurchase of own shares on 19.04.202419.4.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 19 April 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 19.04.2024 Espoo, Finland – On 19 April 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL430,8933.30CEUX--BATE--AQEU--TQEX--Total430,8933.30 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of

Landsbankinn hf.: Results of the 2024 AGM of Landsbankinn19.4.2024 20:48:08 CEST | Press release

The annual general meeting (AGM) of Landsbankinn, held on 19 April 2024, agreed to pay a dividend amounting to ISK 16,535 million to shareholders. The dividend is equivalent to 50% of 2023 profits. The dividend will be paid in two instalments, firstly on 24 April 2024 and secondly on 16 October 2024. As a result, total dividend paid by the Bank in 2013-2024 amounts to ISK 191.7 billion. At the AGM, held in Reykjastræti 6, Helga Björk Eiríksdóttir, Chairman of the Board of Directors, delivered the report from the Board for 2023. Lilja Björk Einarsdóttir, CEO, spoke of the Bank’s operation, strategy and activities in the past operating year. The annual financial statement for the past operating year was approved, as was the proposed Remuneration Policy and remuneration to Directors of the Board. The AGM elected the Auditor General (Ríkisendurskoðun) as auditor of Landsbankinn hf. for the 2024 operating year. The Auditor General, in accordance with an authorisation to outsource tasks, and

SKEL fjárfestingafélag hf.: Styrkás finalizes the purchase of Stólpi Gámar ehf. and affiliated companies.19.4.2024 19:20:57 CEST | Press release

Reference is made to the announcement dated 31 January 2024, regarding Styrkás hf., a company 69.64% owned by SKEL fjárfestingafélag hf., signing a purchase agreement to acquire 100% of the shares in six subsidiaries of Máttarstólpi ehf. The purchase agreement was subject to the approval of the Competition Authority. The transaction was finalized today with payment of purchase price and delivering of shares in the following companies: - Stólpi Gámar ehf., id. 460121-1590, Klettagörðum 5, 104 Reykjavík: - Stólpi Smiðja ehf., id. 460121-1750, Klettagörðum 5, 104 Reykjavík; - Klettskjól ehf., id. 460121-0510, Klettagörðum 5, 104 Reykjavík; - Stólpi ehf., 460121-0430, Klettagörðum 5, 104 Reykjavík; - Tjónaþjónustan ehf., id. 460121-1670, Klettagörðum 5, 104 Reykjavík; - Alkul ehf., id. 491020-0830, Haukdælabraut 48, 113 Reykjavík. collectively referred to as "the sold companies". These companies will continue to be operated on a consolidated basis. The Enterprise value of the sold companie

HiddenA line styled icon from Orion Icon Library.Eye